Antagonists and agonists of LDCAM and methods of use

Details for Australian Patent Application No. 2004261941 (hide)

Owner Amgen Inc.

Inventors Galibert, Laurent J.; Yan, Wei

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004261941

PCT Pub. Number WO2005/012530

Priority 60/490,027 25.07.03 US

Filing date 23 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 10 April 2008

International Classifications

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/012530 Priority application(s): WO2005/012530

10 April 2008 Application Accepted

  Published as AU-B-2004261941

7 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004261948-Fabrics with V-guides

2004261936-Short interfering RNA as an antiviral agent for Hepatitis C